Navigation Links
Dyadic International Launches FibreZyme® G5000 High Performance Powder Pulp and Paper Enzyme in Booth #1065 at Tissue World Americas Conference
Date:3/14/2012

JUPITER, Fla., March 14, 2012 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the industrial enzyme, bioenergy, and biopharmaceutical industries, announced today that it will launch FibreZyme® G5000, a next generation, high performance powder enzyme designed to improve paper quality and improve the economics of various pulp and paper manufacturing processes, in Booth #1065 at the Tissue World Americas conference and exhibition being held at the Miami Beach Convention Center in Miami, Florida from March 20th to March 23rd, 2012.

(Logo: http://photos.prnewswire.com/prnh/20110621/CL06708LOGO )

Thomas O'Shaughnessy, Vice President Sales & Marketing stated, "FibreZyme® G5000 is a great addition to our current FibreZyme® series of products and provides further evidence of the value-adding capabilities of Dyadic's C1 platform technology. FibreZyme® G5000 operates under wide pH and temperature ranges allowing for seamless integration into most pulp and paper manufacturing processes."

Specific attributes of FibreZyme® G5000 include the following:

  • Reduces fiber raw material costs and petroleum-derived chemical usages
  • Reduces pulp refining energy requirements
  • Increases paper machine production rates and efficiencies
  • Improves softness in tissue production
  • Enhances pulp drainage rates and reduces paper drying demand
  • Enhances and restores fiber strength and increases inter-fiber bonding through fibrillation

FibreZyme® G5000 is produced using a variant of Dyadic's patented and proprietary C1 platform technology which Dyadic designated as the "white strain" process.  Developed through sustained efforts at Dyadic's research and development facility in the  Netherlands, the white strain produces significantly less background proteins, providing a clean background host for targeted production. These changes allow for more efficient and economical industrial scale production of highly targeted enzymes and proteins at greater purity levels.  For more information about FibreZyme® G5000, please visit Dyadic's pulp and paper website at www.FibreZyme.com.

Tissue World Americas is the only conference and exhibition targeted at North and South American producers, converters, distributors, traders and suppliers of soft hygiene tissue paper. The event will include a technical conference covering new developments in the tissue business and provide a unique opportunity to learn about new techniques and methods to improve operations and profits.

About Dyadic

Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzyme and protein products for the industrial enzyme, bioenergy, and biopharmaceutical industries.  Please visit Dyadic's website at www.dyadic.com.

Cautionary Statement for Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.


'/>"/>
SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dyadic International Extends Collaboration With The Scripps Research Institute
2. Dyadic International Strengthens Management Team
3. Dyadic International to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference
4. Dyadic International Engages The Abraham Group as Strategic Advisor
5. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
6. Dyadic International to Announce Second Quarter 2010 Financial Results and Hold Conference Call on August 13, 2010
7. Dyadic International Raises $3 Million in Private Placement of Convertible Notes
8. Dyadic International to Announce Third Quarter 2010 Financial Results and Hold Conference Call on November 15, 2010
9. Dyadic International Reports 2010 Third Quarter Financial Results
10. Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform
11. Dyadic International Reports 2010 Fiscal Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... June 23, 2016  Blueprint Bio, a company dedicated ... the medical community, has closed its Series A funding ... . "We have received a commitment from ... we need to meet our current goals," stated ... the runway to complete validation on the current projects ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
(Date:6/22/2016)... 2016 Cell Applications, Inc. and StemoniX ... produce up to one billion human induced pluripotent ... week. These high-quality, consistent stem cells enable researchers ... spend more time doing meaningful, relevant research. This ... manufacturing process that produces affordable, reliable HiPSC for ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):